Global Acute Lymphocytic/Lymphoblastic leukemia Market 2015-2019

2015-11-11
Price :
Published : Nov-2015
No. of Pages : 65

Global Acute Lymphocytic Leukemia Market 2015-2019

Covering: An in-depth study of the acute lymphocytic leukemia market and segmentation by route of administration (oral and parenteral), by type of molecules (biologics and small molecules), and by geography (the Americas, EMEA, and APAC). The report also presents a detailed analysis of the top companies operating in the market, including Amgen, Bristol-Myers Squibb, and Novartis.

Market landscape of acute lymphocytic leukemia

Acute lymphocytic leukemia or acute lymphoblastic leukemia, is a malignancy of the blood cells that affects the lymphoblasts or leukemic blasts, which witnesses an uncontrolled cell division. The main symptoms a patient exhibits are weakness, tiredness, dizziness, fever, shortness of breath, frequent infections, bruising, and bleeding.

Currently, the disease cannot be cured completely but the risk can be reduced by administering medication.

The market research analysts expect the global acute lymphocytic leukemia market to grow at a steady rate and post a CAGR of over 4% during the forecast period. One of the major factors contributing to the growth of the market is the provision for orphan drugs. For instance, in the US, orphan designation for a drug means incentives like tax credits for qualified clinical testing, exemption from prescription drug user fees unless indicated for additional non-orphan indications, and market exclusivity for seven years.

Segmentation of the acute lymphocytic leukemia market by route of administration

  • Oral
  • Parenteral

Many medications are administered through the oral route to guarantee a systemic effect. The oral route is a sub-division of enteral administration and is considered to be one of the safest and most preferred routes of drug administration.

Geographical segmentation of the acute lymphocytic leukemia market

  • Americas
  • APAC
  • EMEA

With a share of over 49%, the Americas dominated the acute lymphocytic leukemia market, with the US being the major revenue contributor. The Americas is closely followed by the EMEA and the APAC region and the market is expected to follow a similar trend during the forecast period.

Competitive landscape and key vendors

The acute lymphocytic leukemia market is marked by the presence of both global and local drug manufacturers with varied product portfolios containing generic and off- label drugs as well as branded therapies. Besides, the high level of unmet medical need is expected to give a platform to the vendors to develop products to cater to relevant areas and enhance their market shares.

Primary vendors in this market are –

  • Amgen
  • Bristol-Myers Squibb
  • Novartis

Other prominent vendors included in this report are Ariad, Arno Therapeutics, Baxter, Boehringer Ingelheim, ERYTECH Pharma, Fate Therapeutics, Jazz Pharmaceuticals, Orphan Europe, Otsuka, Ono Pharmaceuticals, Onconova Therapeutics, Pfizer, Regeneron Pharmaceuticals, Sanofi, and Sigma-Tau Pharmaceuticals.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019?
  • What are the key factors driving the global acute lymphocytic leukemia market?
  • What are the key market trends impacting the growth of the global acute lymphocytic leukemia market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global acute lymphocytic leukemia market?
  • What are the market opportunities and threats faced by the vendors in the global acute lymphocytic leukemia market?
  • What are the trending factors influencing the market shares of the Americas, EMEA, and APAC?
  • What are the key outcomes of the five forces analysis of the global acute lymphocytic leukemia market?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

Micro Labs Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization's business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, amlozaar, angiplat, angizaar, and other products. Micro Labs offers products in various therapeutic areas such as analgesics and anti pyretics, anti-allergics, anti-anginals, anti-arrhythmics, anti-asthmatics and bronchodilators, anti-bacterials and others. The organization concentrates on the development of formulations in various dosage forms including solid dosage, liquid dosage, sterile preparations, injectables, creams and ointments among others. It has operations across Asia, Europe, Latin......
$250

Iconic Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Iconic Therapeutics Inc (Iconic Therapeutics) is a biopharmaceutical company that provides translation of scientific insight into breakthrough medicines. The company offers development of tissue factor in angiogenesis, inflammation, and metastasis that led to develop new approach to retinal disease and cancer. It provides ICON-1 product that offers novel immune-conjugate fusion protein that works with the body's immune system to address the root causes of acute vision loss in AMD. The company's product is used in treatments in course of infections causing blindness. Iconic Therapeutics is headquartered in South San Francisco, California, the US. Iconic Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analy......
$250

Humanigen Inc (HGEN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Humanigen Inc(Humanigen) formerly known as KaloBios Pharmaceuticals Inc, is a development stage biopharmaceutical company that develops medicines for neglected and rare diseases. The company offers benznidazole, a nitroimidazole derivative used for the treatment of Chagas disease, a parasitic infection caused due to protozoan organism called Trypanosoma cruzi. Ifabotuzumab(anti-EphA3) and Lenzilumab(anti-GM-CSF), recombinant monoclonal antibodies, used for the treatment of solid tumors and their micro environment; and certain hematologic malignancies such as chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML), respectively.The company has developed the recombinant monoclonal antibodies using its proprietary drug discovery technology called Humaneer......
$250

MI Bioresearch Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous models, orthotopic models, metastasis models, disseminated models and PDX models. MI also offers services such as validation, candidate selection, optimization, modeling, PK/ PD profiling, biodistribution, custom models, consulting, and ex-vivo. The institute serves pharmaceutical, diagnostics, and medical device sectors. Molecular Imaging is headquartered in Ann Arbor, Michigan, the US. MI Bioresearch Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensi......
$250

Interprotein Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Interprotein Corp (Interprotein) is a drug discovery company that conducts research and develops small molecule drugs. The company provides IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E and CD94 inhibitor; KIR and HLA-C inhibitor; gp130 inhibitor and RUNX1 and CBFß inhibitor products. Its IL-6 inhibitor is used in the treatment of Castleman's disease, rheumatoid arthritis and juvenile idiopathic arthritis, cachexia and various kinds of inflammatory and autoimmune diseases. The company develops small molecule drugs based on protein interactions. It also collaborates with other pharmaceutical companies. Interprotein is headquartered in Osaka, Japan. Interprotein Corp - Pharmaceuticals & Healthcare - Deals and ......
$250

Carondelet Health Network – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Carondelet Health Network (Carondelet) is a healthcare service organization that serves through its network of hospitals including St. Mary's Hospital, St. Joseph's Hospital and Holy Cross Hospital. The organization provides a wide range of medical and treatment services such as neurology or neurosurgery services, women care services, heart and vascular services, orthopedic care services, behavioral health services, diabetes care, dialysis, and emergency care services. It also provides services in lithotripsy, nasal reconstructive surgery, gastroenterology, imaging, robotic surgery, wound care, and other areas. The organization mainly functions through medical centers and clinics in the US. Carondelet is headquartered in Tucson, Arizona, the US. Carondelet Health Network - Ph......
$250

UNeMed Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary UNeMed Corp (UneMed), a subsidiary of University of Nebraska Medical Center is a healthcare service provider that offers technology transfer and commercialization services. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup formation and licensing process. Its technologies includes various categories such as therapeutics, diagnostics, drug delivery, research tools, medical devices, software, and educational materials. UneMed provides intellectual property protection and commercialization services for inventions developed with processing material transfer agreements and confidentiality disclosure agreements. The company has a portfolio of technologies available for licensing. It offers technology licensing process fo......
$250

University of Texas Health Science Center at Houston – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary University of Texas Health Science Center at Houston (UTHealth), a subsidiary of University of Texas System is an educational institution that provides research, education and patient care services. The university operates with schools of biomedical informatics, biomedical sciences, dentistry, medicine, nursing and public health. It offers clinical research education course that is conducted by clinical trial research professionals and examines the entire clinical trial process. The university's teaching hospitals include Memorial Hermann-Texas Medical Center, Children's Memorial Hermann Hospital and Harris Health Lyndon B. Johnson General Hospital. UTHealth is headquartered in Houston, Texas, the US. University of Texas Health Science Center at Houston - Pharmaceuticals & He......
$250

Tesaro Inc (TSRO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI, the company's first commercial product is approved for use in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. The company distributes the product in the US principally through specialty distributors and specialty pharmacy channel. Its development portfolio includes novel cancer and supportive care product candidates in various development stages. Tesaro is headquartered in Waltham, Massachusetts, the US.......
$250

PhotoMedex Inc (PHMD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PhotoMedex Inc (PhotoMedex) is a medical device company that provides dermatological solutions. The company offers Neova, Tricomin and IAMIN products. Its products are used in the treatment of skin diseases and conditions such as psoriasis, vitiligo, acne, actinic keratosis. PhotoMedex provides scientific development and has led to a broad range of FDA clearances. The company provides Copper Peptide technology for skin health, hair care and wound care. Its Neova products are used in therapeutic skin care and LED therapy for acne and photodamage. The company caters to dermatologists, professional aestheticians and consumers in the US. PhotoMedex is headquartered in Willow Grove, Pennsylvania, the US. PhotoMedex Inc (PHMD) - Pharmaceuticals & Healthcare - Deals and Alliances Pr......
$250